A carregar...
Tuftsin Combines With Remyelinating Therapy and Improves Outcomes in Models of CNS Demyelinating Disease
Though promoting remyelination in multiple sclerosis (MS) has emerged as a promising therapeutic strategy, it does not address inflammatory signals that continue to induce neuronal damage and inhibit effectiveness of repair mechanisms. Our lab has previously characterized the immunomodulatory tetrap...
Na minha lista:
| Publicado no: | Front Immunol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6283261/ https://ncbi.nlm.nih.gov/pubmed/30555470 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.02784 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|